Kinetic variable most useful for identifying malignant MRI-detected breast lesions identified

Aug 19, 2009

Breast MRI allows physicians to evaluate suspicious lesions using a variety of variables. Researchers have found though that computer-aided kinetic information can help significantly in distinguishing benign from malignant suspicious breast lesions on MRI, according to a study published in the September issue of the American Journal of Roentgenology (AJR).

In the study, performed at the University of Washington Medical Center, researchers analyzed and compared the computer-aided evaluation variables of 125 suspicious breast lesions. Three different kinetic curves (washout, plateau and persistent), were compared along with lesion morphology (size and shape). "We wanted to clarify which, of the many variables that reflect kinetics, were most predictive of malignancy, said Constance Lehman, MD, lead author of the study. "We found overlap in kinetic patterns across benign and , but we did determine that the "most suspicious" curve type, washout, was useful in separating benign from malignant lesions," said Dr. Lehman.

"Of lesions with the most suspicious curve type (any washout), 45.7 percent were malignant compared with 20.0 percent with plateau and 13.3 percent with entirely persistent enhancement," she said.

"We continue to study the specific features on MRI most predictive of . We know that the morphology of the lesion is extremely important, but our study also supports the use of kinetic features in lesion assessment. The "most suspicious" curve, washout, does seem to help distinguish benign from malignant lesions," said Dr. Lehman.

"In breast MRI, it is important to know which variables are most important for predicting malignancy because they help us in determining whether or not a lesion needs to be biopsied or not," she said.

More information: This study appears in the September issue of the American Journal of Roentgenology.

Source: American Roentgen Ray Society

Explore further: Amgen misses 1Q views as higher costs cut profit

add to favorites email to friend print save as pdf

Related Stories

Melanomas may appear noticeably different than other moles

Jan 21, 2008

A preliminary study suggests that melanomas have a different appearance than other irregular skin moles (i.e., are “ugly ducklings”), according to a report in the January issue of Archives of Dermatology, one of the JAMA/Archives ...

Recommended for you

Amgen misses 1Q views as higher costs cut profit

21 hours ago

Despite higher sales, biotech drugmaker Amgen's first-quarter profit fell 25 percent as production and research costs rose sharply, while the year-ago quarter enjoyed a tax benefit. The company badly missed ...

Valeant, Ackman make $45.6B Allergan bid

Apr 22, 2014

Valeant Pharmaceuticals and activist investor Bill Ackman have unveiled details of their offer to buy Botox maker Allergan, proposing a cash-and-stock deal that could be worth about $45.6 billion.

User comments : 0

More news stories

Amazon Prime wins streaming deal with HBO

Amazon scored a deal Wednesday to distribute old shows from premium cable TV channel HBO to its monthly Prime subscribers, landing a blow on rival Netflix in the streaming video battle.